Sixth Tone·3 min read·medium
Developed ALS Therapy Shows Early Trial Promise
S
Sixth Tone
✦AI Summary
Researchers in China have reported promising early results for RAG-17, an experimental siRNA-based therapy for a genetic form of ALS. The small-scale trial showed that the drug was well-tolerated and successfully reduced key disease-related biomarkers.
Chinese researchers have reported encouraging early results for a domestically developed experimental therapy targeting a genetic form of amyotrophic lateral sclerosis, or ALS. In a six-patient trial published this month in Nature Medicine, the drug was generally well tolerated and reduced key disease-related biomarkers.
healthsciencetechnology
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in